Stay updated on Immune Response in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immune Response in NSCLC Clinical Trial page.

Latest updates to the Immune Response in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe site-wide notice about NIH’s terminology transition and related updates is no longer displayed.SummaryDifference1%

- Check19 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.2 to v3.8.0, while the study record remains inaccessible.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov error page footer updates its revision identifier from v3.7.1 to v3.7.2, while the study record remains inaccessible.SummaryDifference0.2%

- Check40 days agoChange DetectedThe ClinicalTrials.gov error page displays an updated site revision number in its footer.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. This represents an access restriction rather than an update to the page content.SummaryDifference21%

Stay in the know with updates to Immune Response in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Response in NSCLC Clinical Trial page.